Alves P, Camargo L, Souza G, Mortari M, Homem-de-Mello M
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006031
PMC: 11860133.
DOI: 10.3390/ph18020217.
Hayashi G, Naito T, Miura S, Iwamoto N, Usui Y, Bando-Shimizu M
Nat Commun. 2024; 15(1):10723.
PMID: 39715753
PMC: 11666718.
DOI: 10.1038/s41467-024-54902-x.
Colas K, Bindl D, Suga H
Chem Rev. 2024; 124(21):12213-12241.
PMID: 39451037
PMC: 11565579.
DOI: 10.1021/acs.chemrev.4c00422.
Camargo L, Gering I, Mastalipour M, Kraemer-Schulien V, Bujnicki T, Willbold D
ACS Chem Neurosci. 2024; 15(14):2600-2611.
PMID: 38957957
PMC: 11258689.
DOI: 10.1021/acschemneuro.4c00089.
Tapia-Arellano A, Cabrera P, Cortes-Adasme E, Riveros A, Hassan N, Kogan M
J Nanobiotechnology. 2024; 22(1):248.
PMID: 38741193
PMC: 11092257.
DOI: 10.1186/s12951-024-02526-0.
Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins.
Callahan A, Gandhesiri S, Travaline T, Reja R, Salazar L, Hanna S
Nat Commun. 2024; 15(1):1813.
PMID: 38418820
PMC: 10901774.
DOI: 10.1038/s41467-024-45634-z.
Differential Detection of Amyloid Aggregates in Old Animals Using Gold Nanorods by Computerized Tomography: A Pharmacokinetic and Bioaccumulation Study.
Jara-Guajardo P, Morales-Zavala F, Bolanos K, Giralt E, Araya E, Acosta G
Int J Nanomedicine. 2024; 18:8169-8185.
PMID: 38169997
PMC: 10759924.
DOI: 10.2147/IJN.S435472.
Synthesis and applications of mirror-image proteins.
Harrison K, Mackay A, Kambanis L, Maxwell J, Payne R
Nat Rev Chem. 2023; 7(6):383-404.
PMID: 37173596
DOI: 10.1038/s41570-023-00493-y.
Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition.
Ruan Y, Xiong Y, Fang W, Yu Q, Mai Y, Cao Z
J Nanobiotechnology. 2022; 20(1):322.
PMID: 35836190
PMC: 9281113.
DOI: 10.1186/s12951-022-01524-4.
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo.
Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J
Cell Rep Med. 2022; 3(5):100630.
PMID: 35584626
PMC: 9133466.
DOI: 10.1016/j.xcrm.2022.100630.
Phage display derived peptides for Alzheimer's disease therapy and diagnosis.
Zhang X, Zhang X, Gao H, Qing G
Theranostics. 2022; 12(5):2041-2062.
PMID: 35265198
PMC: 8899571.
DOI: 10.7150/thno.68636.
Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
Guo Y, Hu Z, Wang Z
Front Mol Neurosci. 2022; 14:778955.
PMID: 35002620
PMC: 8733658.
DOI: 10.3389/fnmol.2021.778955.
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases.
Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone M
Pharmaceutics. 2021; 13(11).
PMID: 34834311
PMC: 8623286.
DOI: 10.3390/pharmaceutics13111897.
Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer's Disease.
Mamsa S, Meloni B
Front Mol Neurosci. 2021; 14:759729.
PMID: 34776866
PMC: 8581540.
DOI: 10.3389/fnmol.2021.759729.
A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.
Yu S, Lu Y, Su A, Chen J, Li J, Zhou B
Adv Sci (Weinh). 2021; 8(19):e2101848.
PMID: 34363355
PMC: 8498877.
DOI: 10.1002/advs.202101848.
Racemization in Post-Translational Modifications Relevance to Protein Aging, Aggregation and Neurodegeneration: Tip of the Iceberg.
Dyakin V, Wisniewski T, Lajtha A
Symmetry (Basel). 2021; 13(3).
PMID: 34350031
PMC: 8330555.
DOI: 10.3390/sym13030455.
Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer's Disease Development.
Urban A, Pavlov K, Kamynina A, Okhrimenko I, Arseniev A, Bocharov E
Molecules. 2021; 26(10).
PMID: 34068293
PMC: 8153327.
DOI: 10.3390/molecules26102897.
Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
Nonaka M, Mabashi-Asazuma H, Jarvis D, Yamasaki K, Akama T, Nagaoka M
PLoS One. 2021; 16(1):e0241157.
PMID: 33406123
PMC: 7787448.
DOI: 10.1371/journal.pone.0241157.
Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease.
Olubiyi O, Olagunju M, Strodel B
Molecules. 2019; 24(24).
PMID: 31842406
PMC: 6943517.
DOI: 10.3390/molecules24244551.
Pre-Clinical Safety and Efficacy Evaluation of Amytrap, a Novel Therapeutic to Treat Alzheimer's Disease.
Gandbhir O, Sundaram P
J Alzheimers Dis Rep. 2019; 3(1):77-94.
PMID: 31259305
PMC: 6597960.
DOI: 10.3233/ADR-190107.